课题基金 / 基金详情

Regulation of Expression of Thrombomodulin on the Cultured Human Umbilical Vein Endothelila Cells and Pathomechanism of Thrombosis

Regulation of Expression of Thrombomodulin on the Cultured Human Umbilical Vein Endothelila Cells and Pathomechanism of Thrombosis
人脐静脉内皮细胞血栓调节蛋白表达调控及血栓形成机制
批准号:
04454574
负责人:
MARUYAMA Ikuro
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994

项目摘要

项目成果

MARUYAMA Ikuro的其他基金

相关文献

中文摘要
翻译
本文从凝血酶受体和血栓调节蛋白的表达和动态调控机制,凝血酶受体和凝血酶调节蛋白表达的调控因素,凝血酶激活时凝血酶释放肽的测定方法的建立,凝血酶通过凝血酶释放肽的信号转导,凝血酶/蛋白C蛋白S天然抗凝系统的总体评价方法等方面进行了研究。结果表明:1)TM受到各种刺激的双重调节,并伴随着TR2的升高。2)氧化低密度脂蛋白和晚期糖基化内皮细胞下调TM的表达,提示这些因素不仅是动脉粥样硬化的危险因素,也是血栓形成的危险因素。3)我们成功地建立了血清TRRP的检测方法。4)凝血酶激活tr受体,激活核因子kappaB,这可能是凝血酶刺激细胞事件的主要途径。5)我们建立了一种新的体外评价TM/蛋白C和S蛋白天然抗凝系统的方法。通过向血浆中加入重组TM来检测凝血酶原酶抑制率。约15-30%的胶原病、心肌梗死、脉管炎综合征、脑梗塞患者存在RTM耐药现象,提示氧化型低密度脂蛋白和糖化蛋白可能随着tR的增加而下调TM,作为血栓前因子。因此,凝血酶通过受体的信号转导可能导致细胞增殖和血栓形成。这种血栓前状态部分是通过对TM耐药性的TRRP评估来检测的。
英文摘要
We investigated on 1) regulatrory mechanisims of the expression and dynamics of thrombin receptor (TR) and thrombomodulin (TM), 2) factors which regulate the expression of these receptors, 3) establishment of assay method of TR released peptide (TRRP) upon thrombin activation, 4) signal transduction of thrombin through TR,5) total evaluation method of TM/protein C-protein S natural anticoagulant system.As results, we obtained as follows :1) TM is doun-regulated by the stimulation with various stimulus and this is accompanied with increment in TR.2) Oxdized LDL and advanced glycation endoproducts down-regulated the expression of TM suggesting that these factors act as risk factors not only for atherosclerosis but also for thrombosis.3) We succeeded the establishment of assay method of TRRP in serum. This peptide was increased in the serum from diabetes melitus patients with vascular complications.4) Thrombin activates TR receptor and results the activation of NF kappaB.This may be a main pathway in cellular events upon thrombin stimulation.5) We established the new test for evaluation of TM/protein C and protein S natural anticoagulant system in vitro. We measured prothrombinase inhibition rate by recombinat TM added to the plasma. Resistant for rTM was observed about 15-30% patients with collagen diseases, myocardial infarction, vasulitis syndrome, cerebral infarction.Based on these data, oxidized LDL and glycated proteins may down-regulate TM with the increment in TR and act as prothrombotic factors. Thus signal transduction of thrombin through TR may result proliferation and thrombosis. This prothrombotic state is detected in part by the assessment of TRRP of TM resistance.
期刊论文(62)
专著(0)
科研奖励(0)
会议论文
T.Nakajima,I.Maruyama: "Involvement of NF-κB activation in thrombin-induced human vascular smooth muscle cell proliferation." Biochem.Biophys.Res.Commun.204. 950-955 (1994)
T.Nakajima、I.Maruyama:“NF-κB 激活参与凝血酶诱导的人血管平滑肌细胞增殖。”Biochem.Biophys.Res.Commun.204(1994)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Abe,I.Maruyama,et al.: "Increased heparin-releasable platelet factor 4 and D dimer in patients one month after onset of acute myocardial infarction:persistent activation of platelets and the coagulation fibrinolysis." Int.J.Cardiol.47. S7-S12 (1994)
S.Abe,I.Maruyama,et al.:“急性心肌梗死发病后 1 个月患者肝素可释放血小板因子 4 和 D 二聚体增加:血小板持续激活和凝血纤溶。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.Kishida,I.Maruyama,et al.: "Immobilization of human thrombomodulin onto(ether urethane urea)for developing antithrombohgenic blood-contacting materials." Biomaterials. 15. 848-852 (1994)
A.Kishida、I.Maruyama 等人:“将人血栓调节蛋白固定在(乙醚尿烷脲)上,用于开发抗血栓形成血液接触材料。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 29 条
    Cellular and molecular mechanism of blood sludging/skimming. Causative role of cancer exosomes and their pathophysiological view points
    • 批准号:
      18K19587
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $3.99万
    • 财政年份:
      2018
    • 负责人:
      MARUYAMA Ikuro
    • 依托单位:
    Novel therapeutic proposal for DIC/Shock: from Damage-Sensing/-Control to Damage Resolution
    • 批准号:
      17H04363
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.9万
    • 财政年份:
      2017
    • 负责人:
      MARUYAMA Ikuro
    • 依托单位:
    Pathophysiological significance of two types of DAMPs, naked- and exosomal type.
    • 批准号:
      16K15763
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.16万
    • 财政年份:
      2016
    • 负责人:
      MARUYAMA Ikuro
    • 依托单位:
    Proposal of novel concept, Exosome cargo as a novel DAMPs delivery system
    • 批准号:
      15K15667
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2015
    • 负责人:
      MARUYAMA Ikuro
    • 依托单位: